BMO Capital Maintains Outperform on Exelon, Raises Price Target to $42
Portfolio Pulse from Benzinga Newsdesk
BMO Capital analyst James Thalacker maintains an Outperform rating on Exelon (NASDAQ:EXC) and raises the price target from $40 to $42.
May 03, 2024 | 3:29 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
BMO Capital analyst James Thalacker maintains an Outperform rating on Exelon and raises the price target from $40 to $42.
The increase in price target by BMO Capital reflects a positive outlook on Exelon's stock, suggesting potential upside. This analyst endorsement could lead to increased investor confidence and a short-term positive impact on the stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100